Lung Small Cell Carcinoma — Trials

Lung Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 381
Recruiting: 202
Ph III recruiting: 27
Growth YoY: −1%
Industry share: 43%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (157)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06236997	Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer	not yet recruiting	Phase 2	48	Henan Cancer HospitalOTHER_GOV	1	Feb 1, 2024	clinicaltrials
NCT05703997	FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction(FASTIMMUNE)	not yet recruiting	Phase 2	20	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER